Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis

Overview of attention for article published in Nature Chemical Biology, August 2012

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

blogs: 1 blog
policy: 2 policy sources
twitter: 7 X users
patent: 37 patents

facebook: 7 Facebook pages
googleplus: 1 Google+ user
f1000: 1 research highlight platform

Readers on

mendeley: 632 Mendeley
citeulike: 2 CiteULike

So far, Altmetric has seen 37 patents that reference this research output.

PKM2-BASED NANOGLYCOPEPTIDE ACTIVATOR, PREPARATION METHOD THEREFOR AND USE THEREOF

Application WO-2025236336-A1

World Intellectual Property Organisation (WIPO)

20 Nov 2025

Therapeutic compounds and compositions

Grant US-12428376-B2

United States of America

30 Sep 2025

Pyruvate kinase activators for use in therapy

Grant US-12377093-B2

United States of America

05 Aug 2025

COMPOSITIONS AND METHODS OF TARGETING PYRUVATE KINASE ISOFORM M2 (PKM2)

Application WO-2025137634-A1

World Intellectual Property Organisation (WIPO)

26 Jun 2025

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 33 additional patents.